Mesothelin (MSLN) is a cell surface glycoprotein expressed at a high level on many malignancies including pancreatic adenocarcinoma, stomach cancer, ovarian cancer and epithelioid mesothelioma. This evidence concerns the gene MSLN and malignant epithelioid mesothelioma.